LegalHerald.com comments on recent reports indicating that the U.S. Supreme Court has stated that it will not hear an appeal from Johnson & Johnson regarding a $124 million Risperdal lawsuit judgement against the company. The lawsuit being discussed was filed by the state of South Carolina and claims that Johnson & Johnson’s subsidiary company Ortho-McNeil-Janssen Pharmaceuticals has illegally marketed the antipsychotic drug they produce, Risperdal.
Johnson & Johnson is being sued by a man who alleges his wife died of ovarian cancer after years of using talcum products marketed by the company and bought in stores in Los Angeles County.
The number has almost doubled just within the last few months. Now, according to Digital Journal, more than 2,800 cases have been consolidated in the Eastern District of Louisiana, with an additional 600 lawsuits consolidated by the Court of Common Pleas in Philadelphia, Pennsylvania (MDL 2592).